Skip to content

Author

Ian J. Dryden

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Spindle cell oncocytoma: illustrative case

BACKGROUND Spindle cell oncocytoma (SCO) is a rare, nonadenomatous sellar tumor that often mimics pituitary adenomas both radiographically and clinically, making diagnosis and treatment difficult. OBSERVATIONS A 67-year-old male presented with fatigue and weakness, with MRI revealing an enhancing sellar mass with supra...

Hashim S. Syed, Krishnan Ravindran, Mitra Abdollahi-Neisani et al. · 0 citations
Open access Sep 2026

Circumscribed Meningeal Melanocytic Neoplasms: CNS WHO Grade, Molecular Profile, and Clinical Outcomes

Abstract Circumscribed meningeal melanocytic neoplasms (CMMNs) represent a spectrum of rare central nervous system (CNS) tumors. Knowledge of their clinical behavior and molecular correlates remains limited. In this single‐institution retrospective study, we analyzed 31 patients (14 male, 17 female; median age, 59 year...

Yi Zhu, N. Karbhari, T. Kaufmann et al. · 0 citations
Open access Aug 2026

Intracranial Targeting of Cholesterol Processing Reveals a Therapeutic Vulnerability that Reprograms Glioblastoma and Promotes Antitumor Immunity

These findings establish cholesterol dysregulation–induced metabolic collapse as a promising therapeutic approach for GBM using two FDA-approved drugs: the H1 histamine antagonist clemastine and the retinoid X receptor agonist bexarotene.

Maria J. Ulloa-Navas, Rachel M. Whitehead, Vanessa K. Jones et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.